MA56416A - Détermination de la pureté de protéines multimériques - Google Patents

Détermination de la pureté de protéines multimériques

Info

Publication number
MA56416A
MA56416A MA056416A MA56416A MA56416A MA 56416 A MA56416 A MA 56416A MA 056416 A MA056416 A MA 056416A MA 56416 A MA56416 A MA 56416A MA 56416 A MA56416 A MA 56416A
Authority
MA
Morocco
Prior art keywords
multimeric proteins
purity determination
purity
determination
multimeric
Prior art date
Application number
MA056416A
Other languages
English (en)
Inventor
Jiann-Kae Luo
Kathir Muthusamy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MA56416A publication Critical patent/MA56416A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/06—Illumination; Optics
    • G01N2201/061—Sources
    • G01N2201/06113—Coherent sources; lasers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44756—Apparatus specially adapted therefor
    • G01N27/44795—Isoelectric focusing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MA056416A 2015-05-12 2016-05-11 Détermination de la pureté de protéines multimériques MA56416A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562160341P 2015-05-12 2015-05-12

Publications (1)

Publication Number Publication Date
MA56416A true MA56416A (fr) 2022-05-04

Family

ID=56072452

Family Applications (2)

Application Number Title Priority Date Filing Date
MA056416A MA56416A (fr) 2015-05-12 2016-05-11 Détermination de la pureté de protéines multimériques
MA043987A MA43987A (fr) 2015-05-12 2016-05-11 Détermination de la pureté de protéine multimère

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA043987A MA43987A (fr) 2015-05-12 2016-05-11 Détermination de la pureté de protéine multimère

Country Status (10)

Country Link
US (3) US10520511B2 (fr)
EP (2) EP3885368A1 (fr)
JP (3) JP7240812B2 (fr)
AR (1) AR104610A1 (fr)
AU (2) AU2016261854B2 (fr)
CA (1) CA2984010A1 (fr)
ES (1) ES2881359T3 (fr)
MA (2) MA56416A (fr)
PL (1) PL3294775T3 (fr)
WO (1) WO2016183222A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017095813A1 (fr) 2015-11-30 2017-06-08 Intabio, Inc. Dispositifs et procédés de caracterisation d'échantillon
JP7116059B2 (ja) 2016-11-21 2022-08-09 ジャスト－エヴォテック バイオロジックス、インコーポレイテッド アフリベルセプト製剤及びその使用
EP3668985B1 (fr) 2017-08-17 2021-06-16 Just-Evotec Biologics, Inc. Procédé de purification de protéine glycosylée à partir de galectines et d'autres contaminants de cellules hôtes
MY202872A (en) 2017-11-20 2024-05-28 Just Evotec Biologics Inc Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
KR102691269B1 (ko) 2018-01-29 2024-08-05 인타바이오 엘엘씨 샘플 특성화를 위한 장치, 방법 및 키트
KR102790154B1 (ko) 2018-05-31 2025-04-04 인타바이오 엘엘씨 질량분광법과 인터페이스로 연결된 미소유체 시스템을 위한 소프트웨어
US11573226B2 (en) * 2018-09-10 2023-02-07 Genentech, Inc. Systems and methods for affinity capillary electrophoresis
JP7482853B2 (ja) * 2018-09-10 2024-05-14 ジェネンテック， インコーポレイテッド アフィニティキャピラリ電気泳動のシステム及び方法
US11782023B2 (en) * 2018-12-19 2023-10-10 Regeneron Pharmaceuticals, Inc. Ce-western applications for antibody development
JP2022519246A (ja) * 2019-01-31 2022-03-22 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗体電荷不均一性についてのネイティブマイクロ流体ｃｅ－ｍｓ解析法
US12594557B2 (en) 2019-08-12 2026-04-07 Intabio, Llc Isoelectric focusing devices and fixtures
US11285484B2 (en) 2019-08-12 2022-03-29 Intabio, Llc Multichannel isoelectric focusing devices and high voltage power supplies
WO2022219538A1 (fr) * 2021-04-14 2022-10-20 Dh Technologies Development Pte. Ltd. Détection de fluorescence native pour l'analyse de protéines dans une électrophorèse capillaire
JP2024544607A (ja) * 2021-11-25 2024-12-03 エフ． ホフマン－ラ ロシュ アーゲー 少量の抗体副産物の定量

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP385598A0 (en) * 1998-06-02 1998-06-25 Life Therapeutics Limited Purification of antibodies
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
CA2370749A1 (fr) * 1999-04-20 2000-10-26 Target Discovery, Inc. Procedes de cartographie peptidique de polypeptides, etablissement de profils et systeme de base de donnees bioinformatique
US6818112B2 (en) * 1999-04-20 2004-11-16 Target Discovery, Inc. Protein separation via multidimensional electrophoresis
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
AUPQ743300A0 (en) * 2000-05-11 2000-06-01 Life Therapeutics Limited Separation of avian antibodies
US6927004B2 (en) 2002-03-08 2005-08-09 Asml Netherlands B.V. Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method
US20090134028A1 (en) * 2005-09-22 2009-05-28 Chemicals Evaluation And Research Institute Method of Estimating Effect of Test Chemical on Living Organisms
EP1803814A1 (fr) 2005-12-27 2007-07-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Procédé d'amélioration la capacité de sélection d'anticorps dans une bibliothèque d'affichage de phages
EP2009101B1 (fr) * 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Procede de modification d'anticorps pour purifier un anticorps bispecifique
EP2150617B1 (fr) 2007-06-04 2014-10-22 Regeneron Pharmaceuticals, Inc. Régions d'expression et de stabilité amplifiées
ES2595638T3 (es) * 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
JP4977588B2 (ja) * 2007-12-07 2012-07-18 富士フイルム株式会社 イムノクロマトグラフ方法
MY192182A (en) 2009-06-26 2022-08-04 Regeneron Pharma Readily isolated bispecific antibodies with native immunoglobulin format
BR112013029892A2 (pt) 2011-05-21 2016-12-20 Macrogenics Inc polipeptídeo, molécula de ligação a antígeno, diacorpo e uso de uma porção polipeptídica de uma proteína de ligação a soro desimunizada
GB2504139B (en) * 2012-07-20 2014-12-31 Argen X Bv Antibodies to highly conserved targets produced by the immunisation of Camelidae species
EP2604624A1 (fr) * 2011-12-13 2013-06-19 University College Dublin National University Of Ireland, Dublin Peptides de liaison de l'inhibiteur de protéase de Bowman-Birk (BBO) et utilisations associées pour la séparation, la détection ou la purification du BBI.
EP3517548A1 (fr) * 2012-03-13 2019-07-31 NovImmune S.A. Anticorps bispécifiques facilement isolés avec un format natif d'immunoglobuline
MX2014014891A (es) 2012-06-05 2015-06-17 Regeneron Pharma Metodos para hacer anticuerpos biespecificos completamente humanos usando una cadena ligera comun.
TW202423993A (zh) * 2012-11-14 2024-06-16 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
CN105473612A (zh) * 2013-08-19 2016-04-06 豪夫迈·罗氏有限公司 用羟基磷灰石层析分离双特异性抗体和双特异性抗体生产副产物
WO2015033223A2 (fr) * 2013-09-03 2015-03-12 Novimmune S.A. Molécules de liaison bispécifiques facilement isolées au format natif, mais possédant des régions constantes mutées

Also Published As

Publication number Publication date
US20240280587A1 (en) 2024-08-22
PL3294775T3 (pl) 2021-12-13
EP3294775B1 (fr) 2021-07-14
JP7240812B2 (ja) 2023-03-16
US10520511B2 (en) 2019-12-31
US20200166522A1 (en) 2020-05-28
MA43987A (fr) 2018-12-19
EP3294775A1 (fr) 2018-03-21
JP2021152544A (ja) 2021-09-30
AU2022203033A1 (en) 2022-05-26
HK1252480A1 (zh) 2019-05-24
AU2016261854A1 (en) 2017-11-09
AU2022203033B2 (en) 2025-06-26
US20170045527A1 (en) 2017-02-16
AR104610A1 (es) 2017-08-02
EP3885368A1 (fr) 2021-09-29
WO2016183222A4 (fr) 2017-01-05
JP7137663B2 (ja) 2022-09-14
US12158473B2 (en) 2024-12-03
AU2016261854B2 (en) 2022-05-26
ES2881359T3 (es) 2021-11-29
JP2022171730A (ja) 2022-11-11
WO2016183222A1 (fr) 2016-11-17
JP2018528389A (ja) 2018-09-27
CA2984010A1 (fr) 2016-11-17

Similar Documents

Publication Publication Date Title
MA56416A (fr) Détermination de la pureté de protéines multimériques
IL254516B (en) Proteins specific for cd137
EP3397764A4 (fr) Quantification numérique de protéines
DK3292141T3 (da) Fusionsproteiner
EP3362556C0 (fr) Variants polypeptidiques
DK3197453T3 (da) Kimært protein
EP3191599C0 (fr) Détection de protéines mal-repliées
DE112015006591B8 (de) Stromsensor
EP2976352A4 (fr) Purification de protéines à triple hélice
GB201518792D0 (en) Production of proteins
EP3333331A4 (fr) Structure de construction de maison-conteneur modulaire
EP3360010A4 (fr) Source accordable de bi-photons
LT3237432T (lt) Baltymo gamyba
EP3406336A4 (fr) Nanofeuille de type structure c ur-écorce
DK3730511T3 (da) Proteinoprensning
EP3344278A4 (fr) Protéines de fusion immunoglobuline-insuline
EP3356516A4 (fr) Culture de norovirus humains
EP3436049A4 (fr) Protéine 8 de type angiopoïétine (angptl8)
DK3259358T3 (da) Forøget proteinekspression
EP3471544A4 (fr) Protéines de dystrophine modifiées
HRP20182029T1 (hr) Uti-fuzijski proteini
IL257887A (en) Expression of fc-containing proteins
EP3277701A4 (fr) Synthèse de désosamines
IL254502A0 (en) Solid forms of menaquinols
EP3377633C0 (fr) Production de protéines recombinantes